[1]Patent:US5142056,1992,A
[1]BioorganicandMedicinalChemistryLetters,2013,vol.23,p.3140-3144
[2]TetrahedronLetters,2013,vol.54,p.6137-6141
102123-74-0
102507-18-6
114873-05-1
114873-06-2
119363-63-2
121695-40-7
311767-65-4 | 2,6-Pyridinedicarboxaldehyde,4-chloro- | AA007IDR | MFCD11036215
315706-13-9 | eIF4E/eIF4G Interaction Inhibitor, 4EGI-1 | AA007IWH | MFCD02330020
30148-26-6 | Methanone,(2-chlorophenyl)(1-methyl-1H-imidazol-2-yl)- | AA007JDX | MFCD00792020
143537-62-6 | (S)-6-Oxo-N-(2-oxotetrahydrofuran-3-yl)hexanamide | AA007JWB | MFCD00171363
14279-91-5 | 1-(4-Chlorophenyl)guanidine hydrochloride | AA007KK6 | MFCD00209839
135581-16-7 | 1-(4-(Hydroxyimino)piperidin-1-yl)ethanone | AA007L76 | MFCD08873638
13497-18-2 | Bis[3-(triethoxysilyl)propyl]amine | AA007LLN | MFCD00053750
25702-74-3 | Polysucrose | AA007M68
26820-67-7 | N-Isopropyl-3-nitropyridin-2-amine | AA007MJN | MFCD08692137
135876-30-1 | 1,3-Isobenzofurandione, 5,5'-(9H-fluoren-9-ylidene)bis- | AA007N2W | MFCD30342552